Brain

DiagnaMed Expands with Drug and Clinical Research AI Platform

Leveraging proprietary EEG data from previous and future research studies with BRAIN AGE® Brain Health AI Accelerating clinical trial development…

1 year ago

Pharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.

Strategic equity investment of $15 M to support completion of Pharmazz's pivotal Phase 3 study for Sovateltide to treat patients…

1 year ago

Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke

 Planned Data Monitoring Committee (DMC) meeting recommended continuation of the study after reviewing data from the first 8 patients  Interim data…

1 year ago

Prism Clinical Imaging and Sora Neuroscience Announce Cooperation Agreement

Cooperating in Advanced MRI Technology for Diagnosis and Treatment Planning of Brain Disorders ELM GROVE, WI / ACCESSWIRE / August…

1 year ago

Heart Attack Diagnostics Market to Reach $21.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market Research

The global heart attack diagnostics market is experiencing growth due to several factors such as increase in prevalence of cardiovascular diseases,…

1 year ago

GrayMatters Health Expands Veteran and Civilian Access to FDA-Cleared Prism for PTSD™ Treatment

Clinics in New York and Massachusetts to Offer Self-Neuromodulation Treatment to Help Patients Gain Control of PTSD Symptoms HAIFA, Israel,…

1 year ago

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

3D Printed Breast implants consisting of 200cc in volume of CollPlant's rhCollagen-based bioinks produced on a Stratasys' Origin® printer to…

1 year ago

New Study Reveals Novel Epigenetic Connections Between Retroelements and Aging

LEXINGTON, Ky., Aug. 19, 2024 /PRNewswire/ -- A new study by researchers from Weill Cornell Medicine and the epigenetic company, TruDiagnostic,…

1 year ago

MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End

MIAMI, FL / ACCESSWIRE / August 19, 2024 / MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) "MIRA" or the "Company"), a leading pre-clinical-stage…

1 year ago